This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Foreign Product Alerts: Shwasa Sanjeevani and Golden Dragon Linzi Dong Mai Dan
- Starting date:
- August 11, 2014
- Posting date:
- August 11, 2014
- Type of communication:
- Foreign Product Alert (FPA)
- Subcategory:
- Natural health products
- Source of recall:
- Health Canada
- Issue:
- Undeclared Substance
- Audience:
- General Public
- Identification number:
- RA-40997
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
Background
Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of July 7, 2014, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.
What you should do
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the products listed above in the Canadian marketplace.
Canadians who have these products are advised not to use them, and should consult with a healthcare professional if they have concerns about their health related to the use of these products.
Affected products
Shwasa Sanjeevani and Golden Dragon Linzi Dong Mai Dan
Product description
The product Shwasa Sanjeevani is a dark liquid in a labeled brown bottle. This product is promoted for chronic bronchitis, allergy, wheezing asthma, cough and colds.
The product Golden Dragon Linzi Dong Mai Dan is promoted for pain relief.
Hazard identified
The Medicines and Healthcare Products Regulatory Agency (United Kingdom) warned consumers not to use the product Shwasa Sanjeevani and the Singapore Health Sciences Authority warned consumers not to use the product Golden Dragon Linzi Dong Mai Dan after they were found to contain dexamethasone.
- Dexamethasone is a steroidal prescription drug used to treat inflammatory conditions such as arthritis and allergic reactions. It should only be taken under the supervision of a healthcare professional.
Side effects
Side effects associated with dexamethasone include irregular heartbeat, increased blood pressure, stomach ulcer, blood disorders, skin, muscle and bone damage, and nervous system disorders. Consult with your healthcare professional prior to stopping use, as sudden discontinuation of dexamethasone may cause symptoms of withdrawal.
Place of origin
Unknown
Images (select thumbnail to enlarge - opens in a new window)
Report health or safety concerns
To report a side effect to a health product to Health Canada:
- Call toll-free at 1-866-234-2345
- Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax